Skip to Main Content

Paper Details

OX40-targeted immune agonist antibodies induce potent antitumor immune responses without inducing liver damage in mice.
FASEB Bioadv
1
2021
Author NameAffiliation
David J LynnPrecision Medicine Theme South Australian Health and Medical Research Institute Adelaide SA Australia.
David J LynnFlinders Health and Medical Research Institute Flinders University Bedford Park SA Australia.
  • 1 - 2

Datasets

Release 1.2